SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001654954-21-003655
Filing Date
2021-03-31
Accepted
2021-03-31 17:13:21
Documents
1
Period of Report
2020-12-31
Effectiveness Date
2021-03-31

Document Format Files

Seq Description Document Type Size
1 NT 10-K gtbp_nt10k.htm NT 10-K 25883
  Complete submission text file 0001654954-21-003655.txt   27244
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-40023 | Film No.: 21794538
SIC: 2834 Pharmaceutical Preparations